Matthew Flick Links Urokinase Plasminogen Activator Deficiency to Obesity
Matthew Flick, Professor at University of North Carolina at Chapel Hill, shared on LinkedIn:
”I’m thrilled that our latest publication is now available online at ATVB An American Heart Association Journal.
Here, we show a contribution for urokinase plasminogen activator (uPA) to early development of obesity and metabolic sequelae.
Great work by lead author Woosuk Steve Hur with important contributions from several groups, including those of Alisa Wolberg and James Luyendyk.
Moreover, this was another highly successful collaboration with Department of Regional Health Research, University of Southern Denmark and Else Marie Bladbjerg.”
Read the full article here.
Article: Urokinase Plasminogen Activator Deficiency Delays the Development of Obesity and Metabolic Sequelae
Authors: Woosuk S. Hur, Yesha N. Patel, Sara R. Abrahams, Zimu Wei, Haley E. Hanes, Angelica T. Jameson, Oscar A. Negrón, Nadja B. Pedersen, Mario S.Y. Giacomazzo, Else-Marie Bladbjerg, Alisa S. Wolberg, James P. Luyendyk, Matthew J. Flick
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 27, 2026, 12:27Martin Haluzík on Residual Cardiovascular Risk in Coronary Artery Disease
-
Jan 27, 2026, 12:18Stuart Phillips: Strong Bodies Are Good, Informed Bodies Are Better!
-
Jan 27, 2026, 12:07Daniel Torrent: This Should Be An Ice Cold Take… But Veins Aren’t Arteries
-
Jan 27, 2026, 09:17Paolo Zamboni on CCSVI Associated to Multiple Sclerosis
-
Jan 27, 2026, 09:02Rowan Paul: Platelet Dose Determines Success in PRP Therapy
-
Jan 27, 2026, 08:48Uriel Suárez: Hemi‐Orolingual Angioedema in a Patient With VEXAS Syndrome
-
Jan 27, 2026, 08:23Rossella Crescitelli on Platelets’ and PEVs’ Association with Lung Cancer Metastases
-
Jan 26, 2026, 20:47Michael Makris on Non-Malignant Haematology
-
Jan 26, 2026, 09:15Pablo Corral on Lipid-Lowering Therapy and Cognition: Evidence vs Myth